Tang et al. [5] demonstrated that intratracheal administration of MSC-MVs ameliorated the lung inflammation and restored the pulmonary capillary permeability in a mouse model of LPS-induced ALI, partially through their content of Angiopoietin-1 (Ang-I) mRNA. Here, ANGPT1 is linked to inflammatory response.